Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Sales | 692,878 | 609,266 | 493,451 | 495,269 | 430,414 |
| Cost of Goods | 90,357 | 74,144 | 65,498 | 63,269 | 57,415 |
| Gross Profit | 602,521 | 535,122 | 427,953 | 432,000 | 372,999 |
| Operating Expenses | 231,226 | 175,424 | 180,201 | 154,771 | 149,937 |
| Operating Income | 371,652 | 359,842 | 248,250 | 277,498 | 223,477 |
| Interest Expense | 3,724 | 392 | 26 | 15 | 9 |
| Other Income | 29,519 | 19,536 | 15,350 | 10,701 | 7,580 |
| Pre-tax Income | 397,447 | 378,986 | 263,574 | 288,184 | 231,048 |
| Income Tax | 134,743 | 97,384 | 84,342 | 92,217 | 73,935 |
| Net Income Continuous | 262,704 | 281,602 | 179,232 | 195,967 | 157,113 |
| Net Income | $262,704 | $281,602 | $179,232 | $195,967 | $157,113 |
| EPS Basic Total Ops | 0.14 | 0.16 | 0.10 | 0.11 | 0.09 |
| EPS Basic Continuous Ops | 0.14 | 0.15 | 0.10 | 0.11 | 0.09 |
| EPS Diluted Total Ops | 0.14 | 0.15 | 0.10 | 0.10 | 0.09 |
| EPS Diluted Continuous Ops | 0.14 | 0.15 | 0.09 | 0.10 | 0.08 |
| EBITDA(a) | $382,895 | $371,715 | $259,582 | $283,933 | $229,614 |